These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30794672)

  • 21. Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis.
    Khan I; Krishnan M; Kothawala A; Ashfaq A
    BMC Nephrol; 2011 May; 12():22. PubMed ID: 21595975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort.
    Yong K; Kairaitis L
    Nephrology (Carlton); 2010 Apr; 15(3):288-93. PubMed ID: 20470296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis.
    Wetmore JB; Peng Y; Monda KL; Kats AM; Kim DH; Bradbury BD; Collins AJ; Gilbertson DT
    Am J Nephrol; 2015; 41(4-5):354-61. PubMed ID: 26107376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A single centre study about the effects of HFR on anemia].
    Righetti M; Ferrario GM; Milani S; Serbelloni P; Sessa A
    G Ital Nefrol; 2004; 21 Suppl 30():S168-71. PubMed ID: 15750978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Switch to Erythropoiesis-Stimulating Agent (ESA) Biosimilars versus Maintenance of ESA Originators in the Real-Life Setting: Matched-Control Study in Hemodialysis Patients.
    Minutolo R; Bolasco P; Chiodini P; Sposini S; Borzumati M; Abaterusso C; Mele AA; Santoro D; Canale V; Santoboni A; Filiberti O; Fiorini F; Mura C; Imperiali P; Borrelli S; Russo L; De Nicola L; Russo D
    Clin Drug Investig; 2017 Oct; 37(10):965-973. PubMed ID: 28779268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodiafiltration with endogenous reinfusion with and without acetate-free dialysis solutions: effect on ESA requirement.
    Bolasco PG; Ghezzi PM; Serra A; Corazza L; Murtas S; Mascia M; Cossu M; Ferrara R; Cogoni G; Cadinu F; Casu D; Contu B; Passaghe M; Ghisu T; Ganadu M; Logias F
    Blood Purif; 2011; 31(4):235-42. PubMed ID: 21242676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical parameters after switching to nocturnal haemodialysis: a Dutch propensity-score-matched cohort study comparing patients on nocturnal haemodialysis with patients on three-times-a-week haemodialysis/haemodiafiltration.
    Jansz TT; Özyilmaz A; Grooteman MPC; Hoekstra T; Romijn M; Blankestijn PJ; Bots ML; van Jaarsveld BC
    BMJ Open; 2018 Mar; 8(3):e019900. PubMed ID: 29523566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study.
    Akizawa T; Makino H; Matsuo S; Watanabe T; Imai E; Nitta K; Ohashi Y; Hishida A;
    Clin Exp Nephrol; 2011 Apr; 15(2):248-57. PubMed ID: 21234785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of gender and dialysis adequacy on anaemia in peritoneal dialysis.
    Ryta A; Chmielewski M; Debska-Slizien A; Jagodzinski P; Sikorska-Wisniewska M; Lichodziejewska-Niemierko M
    Int Urol Nephrol; 2017 May; 49(5):903-908. PubMed ID: 28058668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.
    Smith JR; Zimmer N; Bell E; Francq BG; McConnachie A; Mactier R
    Am J Kidney Dis; 2017 Jun; 69(6):762-770. PubMed ID: 28024931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration.
    Krieter DH; Falkenhain S; Chalabi L; Collins G; Lemke HD; Canaud B
    Kidney Int; 2005 Jan; 67(1):349-56. PubMed ID: 15610261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a More Permeable Dialysis Membrane on ESA Resistance in Hemodialysis Patients--A Pilot Investigation.
    Teatini U; Liebchen A; Nilsson LG; Beck W; Longhena GR
    Blood Purif; 2016; 41(1-3):80-6. PubMed ID: 26536083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten-Year Survival of End-Stage Renal Disease Patients Treated with High-Efficiency Online Hemodiafiltration: A Cohort Study of a Center in South East Asia.
    Tiranathanagul K; Susantitaphong P; Srisawat N; Mahatanan N; Tungsanga K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2018; 139(2):150-158. PubMed ID: 29514159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of alternate night nocturnal home hemodialysis on anemia control in patients with end-stage renal disease.
    Poon CK; Tang HL; Wong JH; Law WP; Lam CM; Yim KF; Cheuk A; Lee W; Chau KF; Tong MK; Fung SK
    Hemodial Int; 2015 Apr; 19(2):235-41. PubMed ID: 25251291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.
    Dekker M; Pasch A; van der Sande F; Konings C; Bachtler M; Dionisi M; Meier M; Kooman J; Canaud B
    PLoS One; 2016; 11(4):e0151508. PubMed ID: 27064679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008.
    Spiegel DM; Khan I; Krishnan M; Mayne TJ
    Am J Kidney Dis; 2010 Jan; 55(1):113-20. PubMed ID: 19932539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study.
    Martínez-Castelao A; Cases A; Carballada AT; Iranzo JT; Bronsoms J; Vallès-Prats M; Monserrat DT; Jimenez EM;
    Nefrologia; 2015; 35(2):179-88. PubMed ID: 26300512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change from conventional haemodiafiltration to on-line haemodiafiltration.
    Maduell F; del Pozo C; Garcia H; Sanchez L; Hdez-Jaras J; Albero MD; Calvo C; Torregrosa I; Navarro V
    Nephrol Dial Transplant; 1999 May; 14(5):1202-7. PubMed ID: 10344362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switch of ESA therapy from darbepoetin-alpha to epoetin-beta in hemodialysis patients: a single-center experience.
    Biggar P; Ketteler M; Hennemann H; Dömling R
    Clin Nephrol; 2008 Mar; 69(3):185-92. PubMed ID: 18397717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Lowering Haemoglobin Targets on Patterns of Erythropoiesis-Stimulating Agent Use in Patients on Haemodialysis.
    Hazara AM; Owen SJ; Bhandari S
    Blood Purif; 2016; 41(4):287-92. PubMed ID: 26820617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.